MedTrace Logo

Modifiers of Tenofovir in the Female Genital Tract

NCT03377608 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-05-01

No results posted yet for this study

Summary

Two-armed, single visit, pharmacokinetic study to compare tenofovir diphosphate concentrations in cervical tissues of women on Depo-Provera contraception vs non-hormonal contraception.

Conditions

Interventions

DRUG

Tenofovir Disoproxil Fumarate

Two cervical biopsies, blood plasma, PBMC, urine, and two cervicovaginal swabs will be collected at a single study visit

DRUG

Depo-Provera

Two cervical biopsies, blood plasma, PBMC, urine, and two cervicovaginal swabs will be collected at a single study visit

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-17
Primary Completion
2018-03-29
Completion
2018-04-02
FDA Drug
Yes

Countries

  • Uganda

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03377608 on ClinicalTrials.gov